mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.1 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.21 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.1 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.1 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |